Current recommendations for revascularization of non-infarct-related artery in patients presenting with ST-segment elevation myocardial infarction and multivessel disease

被引:2
|
作者
Towashiraporn, Korakoth [1 ]
机构
[1] Mahidol Univ, Fac Med Siriraj Hosp, Her Majesty Cardiac Ctr, Bangkok, Thailand
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
关键词
ST-segment elevation myocardial infarction; multivessel disease; complete revascularization; percutaneous coronary intervention; infarct-related artery; PERCUTANEOUS CORONARY INTERVENTION; LESION-ONLY REVASCULARIZATION; CARDIOGENIC-SHOCK; SCIENTIFIC STATEMENT; RANDOMIZED-TRIAL; CULPRIT LESION; MANAGEMENT; PLAQUE; STEMI; OUTCOMES;
D O I
10.3389/fcvm.2022.969060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality worldwide. Immediate reperfusion therapy of the infarct-related artery (IRA) is the mainstay of treatment, either via primary percutaneous coronary intervention (PPCI) or thrombolytic therapy when PPCI is not feasible. Several studies have reported the incidence of multivessel disease (MVD) to be about 50% of total STEMI cases. This means that after successful PPCI of the IRA, residual lesion(s) of the non-IRA may persist. Unlike the atherosclerotic plaque of stable coronary artery disease, the residual obstructive lesion of the non-IRA contains a significantly higher prevalence of vulnerable plaques. Since these lesions are a strong predictor of acute coronary syndrome, if left untreated they are a possible cause of future adverse cardiovascular events. Percutaneous coronary intervention (PCI) of the obstructive lesion of the non-IRA to achieve complete revascularization (CR) is therefore preferable. Several major randomized controlled trials (RCTs) and meta-analyses demonstrated the clinical benefits of the CR strategy in the setting of STEMI with MVD, not only for enhancing survival but also for reducing unplanned revascularization. The CR strategy is now supported by recently published clinical practice guidelines. Nevertheless, the benefit of revascularization must be weighed against the risks from additional procedures.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction COMPLETE Trial
    Wood, David A.
    Cairns, John A.
    Wang, Jia
    Mehran, Roxana
    Storey, Robert F.
    Nguyen, Helen
    Meeks, Brandi
    Kunadian, Vijay
    Tanguay, Jean-Francois
    Kim, Hahn-Ho
    Cheema, Asim
    Deghani, Payam
    Natarajan, Madhu K.
    Jolly, Sanjit S.
    Amerena, John
    Keltai, Matyas
    James, Stefan
    Hlinomaz, Ota
    Niemela, Kari
    AlHabib, Khalid
    Lewis, Basil S.
    Nguyen, Michel
    Sarma, Jaydeep
    Dzavik, Vladimir
    Della Siega, Anthony
    Mehta, Shamir R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (22) : 2713 - 2723
  • [32] Complete versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a meta-analysis of randomized trials
    Xu, Haiyan
    Zhang, Xiwen
    Li, Jiangjin
    Liu, Hailang
    Hu, Xiao
    Yang, Jing
    BMC CARDIOVASCULAR DISORDERS, 2019, 19 (1)
  • [33] Comparison of Long-Term Clinical Outcome Between Multivessel Percutaneous Coronary Intervention Versus Infarct-Related Artery-Only Revascularization for Patients With ST-Segment-Elevation Myocardial Infarction With Cardiogenic Shock
    Lee, Joo Myung
    Rhee, Tae-Min
    Kim, Hyun Kuk
    Hwang, Doyeon
    Lee, Seung Hun
    Choi, Ki Hong
    Kim, Jihoon
    Park, Taek Kyu
    Yang, Jeong Hoon
    Song, Young Bin
    Choi, Jin-Ho
    Choi, Seung-Hyuk
    Koo, Bon-Kwon
    Chae, Shung Chull
    Cho, Myeong-Chan
    Kim, Chong Jin
    Kim, Ju Han
    Kim, Hyo-Soo
    Gwon, Hyeon-Cheol
    Jeong, Myung Ho
    Hahn, Joo-Yong
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (24):
  • [34] Management of patients with ST-segment myocardial infarction and multivessel disease: what are the options in 2022?
    Ong, Peter
    Pereyra, Valeria Martinez
    Sechtem, Udo
    Bekeredjian, Raffi
    CORONARY ARTERY DISEASE, 2022, 33 (06) : 485 - 489
  • [35] Staged revascularization vs. culprit-only percutaneous coronary intervention for multivessel disease in elderly patients with ST-segment elevation myocardial infarction
    Lang, Jiachun
    Wang, Chen
    Wang, Le
    Zhang, Jingxia
    Hu, Yuecheng
    Sun, Huajun
    Cong, Hongliang
    Liu, Yin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [36] Long-Term Clinical Outcomes of Infarct-Related Artery versus Multivessel Revascularization in Acute ST-Segment Elevation Myocardial Infarction with Multivessel Disease: An Analysis from Korea Acute Myocardial Infarction Registry
    Lee, Han Cheol
    Choi, Jin Hee
    Kim, Bo Won
    Lee, Hye Won
    Yang, Mi Jin
    An, Sung Gyu
    Oh, Jun-Hyok
    Choi, Junghyun
    Cha, Kwang Soo
    Hong, Taek Jong
    CIRCULATION, 2011, 124 (21)
  • [37] Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease
    Jensen, Lisette Okkels
    Thayssen, Per
    Farkas, Dora Kormendine
    Hougaard, Mikkel
    Terkelsen, Christian Juhl
    Tilsted, Hans-Henrik
    Maeng, Michael
    Junker, Anders
    Lassen, Jens Flensted
    Horvath-Puho, Erzsebet
    Sorensen, Henrik Toft
    Thuesen, Leif
    EUROINTERVENTION, 2012, 8 (04) : 456 - 464
  • [38] Non-infarct-related artery revascularization during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A systematic review and meta-analysis
    Bagai, Akshay
    Thavendiranathan, Paaladinesh
    Sharieff, Waseem
    Al Lawati, Hatim A.
    Cheema, Asim N.
    AMERICAN HEART JOURNAL, 2013, 166 (04) : 684 - +
  • [39] Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction Why, How, and When?
    Berry, Colin
    Collison, Damien
    Mangion, Kenneth
    JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (08) : 731 - 733
  • [40] Impact of successful staged revascularization of a chronic total occlusion in the non-infarct-related artery on long-term outcome in patients with acute ST-segment elevation myocardial infarction
    Yang, Zhen Kun
    Zhang, Rui Yan
    Hu, Jian
    Zhang, Qi
    Ding, Feng Hua
    Shen, Wei Feng
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 165 (01) : 76 - 79